Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kevin H. Maniar, Ian A. Jones, Rayudu Gopalakrishna & C. Thomas Vangsness$suffix/text()$suffix/text(). (2018) Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage. Expert Opinion on Pharmacotherapy 19:2, pages 93-102.
Read now
Read now
Roy D. Altman, Vibeke Strand, Marc C. Hochberg, Allan Gibofsky, Joseph A. Markenson, William E. Hopkins, Byron Cryer, Alan Kivitz, Jennifer Nezzer, Olaolu Imasogie & Clarence L. Young. (2015) Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study. Postgraduate Medicine 127:5, pages 517-528.
Read now
Read now
Allan Gibofsky, Roy Altman, Stephen Daniels, Olaolu Imasogie & Clarence Young. (2015) Low-dose SoluMatrix diclofenac: a review of safety across two Phase III studies in patients with acute and osteoarthritis pain. Expert Opinion on Drug Safety 14:8, pages 1327-1339.
Read now
Read now
Articles from other publishers (23)
Erin Nicholas, Jennifer Cheng & Peter J. Moley. (2023) Non-operative Treatment Options for Osteoarthritis in the Hip. HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery 19:4, pages 486-493.
Crossref
Crossref
V.V. Stroblіa, S.M. Drogovoz & R.V. Lutsenko. (2023) Нетрадиційні методи лікування остеоартрозу колінного суглоба. TRAUMA 24:1, pages 39-45.
Crossref
Crossref
Francesco Oliva, Marco Quaranta, Lucio Cipollaro, Valeria Conti, Emanuela De Bellis, Amelia Filippelli & Nicola Maffulli. (2022) Low-Dose NSAIDs Efficacy in Orthopedic Applications. Sports Medicine and Arthroscopy Review 30:3, pages 147-161.
Crossref
Crossref
Chiara Delbaldo, Matilde Tschon, Lucia Martini, Milena Fini & Giorgia Codispoti. (2022) Benefits of Applying Nanotechnologies to Hydrogels in Efficacy Tests in Osteoarthritis Models—A Systematic Review of Preclinical Studies. International Journal of Molecular Sciences 23:15, pages 8236.
Crossref
Crossref
Yura Kim, Gregory Levin, Nikolay P. Nikolov, Robert Abugov & Rebecca Rothwell. (2022) Concept End Points Informing Design Considerations for Confirmatory Clinical Trials in Osteoarthritis. Arthritis Care & Research 74:7, pages 1154-1162.
Crossref
Crossref
Elena Rezuş, Alexandra Burlui, Anca Cardoneanu, Luana Andreea Macovei, Bogdan Ionel Tamba & Ciprian Rezuş. (2021) From Pathogenesis to Therapy in Knee Osteoarthritis: Bench-to-Bedside. International Journal of Molecular Sciences 22:5, pages 2697.
Crossref
Crossref
Ziqin Cao, Jian Zhou, Zeling Long, Yihan Li, Jingjing Sun, Yingquan Luo & Wanchun Wang. (2020) Targeting nerve growth factor, a new option for treatment of osteoarthritis: a network meta-analysis of comparative efficacy and safety with traditional drugs. Aging 13:1, pages 1051-1070.
Crossref
Crossref
Ziqin Cao, Yajia Li, Wanchun Wang, Shuo Jie, Xuantao Hu, Jian Zhou, Tong Wu, Dilihumaer Aili, Zeling Long, Yihan Li, Pengcheng Dou & Ren Wu. (2020) Is Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta-analysis. BioMed Research International 2020, pages 1-10.
Crossref
Crossref
Delaram Babadi, Simin Dadashzadeh, Mahraz Osouli, Maryam Sadat Daryabari & Azadeh Haeri. (2020) Nanoformulation strategies for improving intestinal permeability of drugs: A more precise look at permeability assessment methods and pharmacokinetic properties changes. Journal of Controlled Release 321, pages 669-709.
Crossref
Crossref
Susanne Hellms, Faikah Gueler, Marcel Gutberlet, Nils Helge Schebb, Katharina Rund, Jan T Kielstein, VanDai VoChieu, Sebastian Rauhut, Robert Greite, Petros Martirosian, Hermann Haller, Frank Wacker & Katja Derlin. (2019) Single-dose diclofenac in healthy volunteers can cause decrease in renal perfusion measured by functional magnetic resonance imaging†. Journal of Pharmacy and Pharmacology 71:8, pages 1262-1270.
Crossref
Crossref
Emma L Parry, Martin J Thomas & George Peat. (2018) Defining acute flares in knee osteoarthritis: a systematic review. BMJ Open 8:7, pages e019804.
Crossref
Crossref
David S. Jevsevar, Peter B. Shores, Kyle Mullen, Danielle M. Schulte, Gregory A. Brown & Deborah S. Cummins. (2018) Mixed Treatment Comparisons for Nonsurgical Treatment of Knee Osteoarthritis: A Network Meta-analysis. Journal of the American Academy of Orthopaedic Surgeons 26:9, pages 325-336.
Crossref
Crossref
Marita Cross, Ludovic Dubouis, Matthieu Mangin, David J. Hunter, Lyn March, Gillian Hawker & Francis Guillemin. (2017) Defining Flare in Osteoarthritis of the Hip and Knee: A Systematic Literature Review — OMERACT Virtual Special Interest Group. The Journal of Rheumatology 44:12, pages 1920-1927.
Crossref
Crossref
Gabriel Calvo Mosquera, Dania Calvo Rodríguez & Amparo González Cal. (2017) Abordaje multifactorial del dolor crónico no neoplásico en Atención Primaria. FMC - Formación Médica Continuada en Atención Primaria 24, pages 1-55.
Crossref
Crossref
Vibeke Strand, Martin Bergman, Jasvinder A. Singh, Allan Gibofsky, Alan Kivitz & Clarence Young. (2017) Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial. Clinical Rheumatology 36:6, pages 1357-1367.
Crossref
Crossref
Mostafa Hossein Beyki, Mosleh Mohammadirad, Farzaneh Shemirani & Ali Akbar Saboury. (2017) Magnetic cellulose ionomer/layered double hydroxide: An efficient anion exchange platform with enhanced diclofenac adsorption property. Carbohydrate Polymers 157, pages 438-446.
Crossref
Crossref
Alexios Carayannopoulos. 2017. Comprehensive Pain Management in the Rehabilitation Patient. Comprehensive Pain Management in the Rehabilitation Patient
373
402
.
Charles Argoff, Bill McCarberg, Jeff Gudin, Srinivas Nalamachu & Clarence Young. (2016)
SoluMatrix
®
Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain
. Pain Medicine 17:10, pages 1933-1941.
Crossref
Crossref
Ashleigh M. Philp, Edward T. Davis & Simon W. Jones. (2016) Developing anti-inflammatory therapeutics for patients with osteoarthritis. Rheumatology, pages kew278.
Crossref
Crossref
Peter Wehling, Carsten Moser & William Maixner. (2016) How does surgery compare with advanced intra-articular therapies in knee osteoarthritis: current thoughts. Therapeutic Advances in Musculoskeletal Disease 8:3, pages 72-85.
Crossref
Crossref
Joseph V PergolizziJrJr, Robert B Raffa, Srinivas Nalamachu & Robert TaylorJrJr. (2016) Evolution to low-dose NSAID therapy. Pain Management 6:2, pages 175-189.
Crossref
Crossref
Charles V. PollackJr.Jr., Deborah B. Diercks, Stephen H. Thomas, Nathan I. Shapiro, John Fanikos, Sharon E. Mace, Zubaid Rafique & Knox H. Todd. (2016) Patient-reported Outcomes from A National, Prospective, Observational Study of Emergency Department Acute Pain Management With an Intranasal Nonsteroidal Anti-inflammatory Drug, Opioids, or Both. Academic Emergency Medicine 23:3, pages 331-341.
Crossref
Crossref
Paul J. Desjardins, Kemi Olugemo, Daniel Solorio & Clarence L. Young. (2015) Pharmacokinetic Properties and Tolerability of Low-dose SoluMatrix Diclofenac. Clinical Therapeutics 37:2, pages 448-461.
Crossref
Crossref